VideoHIVMexican HIV Clinical Forum 2018Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | Courtney Fletcher, PharmDView Video
PTPablo TebasMDVideoHIVMexican HIV Clinical Forum 2018Clinical Update on Integrase Inhibitors: Recent Data | Pablo Tebas, MDView Video
VideoHIVMexican HIV Clinical Forum 2018HIV integrase Inhibitors: A novel mechanisms of action | Francisco Flores Murrieta, PhDView Video
VideoHIVArgentina HIV Clinical Forum 2018Pharmacology and new modes of delivery | David Back, PhDView Video
VideoHIVArgentina HIV Clinical Forum 2018Clinical use of Integrase Inhibitors | Eugenia Negredo, PhDView Video
VideoHIVArgentina HIV Clinical Forum 2018Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhDView Video
VideoHIVArgentina HIV Clinical Forum 2018Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhDView Video
VideoHIVArgentina HIV Clinical Forum 2018HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhDView Video
MBMarta BoffitoMD, PhD, FRCP, MBAVideoHIVNurses & Pharmacists HIV Clinical Forum 2018Clinical case presentation | Marta Boffito, MD, PhD, FRCPView Video
MBMarta BoffitoMD, PhD, FRCP, MBAVideoHIVNurses & Pharmacists HIV Clinical Forum 2018Novel Drug Delivery Systems | Marta Boffito, MD, PhD, FRCPView Video
